Stereotactic Body Radiotherapy Boost with the CyberKnife for Locally Advanced Cervical Cancer: Dosimetric Analysis and Potential Clinical Benefits
Open Access
Abstract
(1) Aim: To compare the treatment plans of stereotactic body radiotherapy (SBRT) with CyberKnife (CK) and high-dose-rate (HDR) intracavitary/interstitial brachytherapy (IC/ISBT) and examine the feasibility of CK-SBRT as a viable alternative to BT in patients with locally advanced cervical cancer (LACC). (2) Methods: A BT plan of 28 Gy in four fractions delivered previously to 20 patients with LACC was compared with a CK plan based on the same CT images with structures delineation for BT. The SBRT treatment plan was further divided according to two different approaches, with the high-risk planning target volume (HR-PTV) defined by the high-risk clinical target volume (HR-CTV) without and with a 5 mm margin, which were named CK-CTV plan and CK-PTV plan, respectively. The dose distributions and dosimetric parameters of the target volumes and organs at risk (OARs) were recorded and compared for the three boost plans. Radiobiological metrics were calculated based on the EUD for the hybrid plans. Additionally, the relationship between tumor volume and tolerance doses for the OARs in the BT plan and CK-PTV plan was investigated. (3) Results: Target coverage was better with the CK plan than with the BT plan, as the D95%, D98%, HI and CI of the CK-CTV plan and CK-PTV plan were higher than those of the BT plan; an exception was the D50%. Similarly, the TCP of the target was also significantly in favor of the CK hybrid plans (p < 0.01). For the OARs, the CK-CTV plan was superior to the BT plan as regards the rectum D2cc, bladder D2cc and bladder Dmax. The CK-PTV plan could achieve dosimetric parameters comparable to those of the BT plan for OARs concerning the small residual tumor volume. The NTCP of the rectum for the WPI+CK-CTV plans was significantly lower than that of the WPI+BT plans (p < 0.01). (4) Conclusions: CK-based SBRT can achieve better target coverage, dose sparing for the OARs and radiobiological effects compared with the BT plan for tumors that are not excessively large. CK-based SBRT could be an alternative option to administer a radiation boost for patients with LACC.Keywords
Funding Information
- Innovation of Science and Technology, Fujian Province (2018Y9001, 2021J01740)
- Natural Science Foundation of Fujian Province (2018Y9001, 2021J01740)
This publication has 45 references indexed in Scilit:
- Stereotactic Body Radiotherapy as an Alternative to Brachytherapy in Gynecologic CancerBioMed Research International, 2013
- Brachytherapy-emulating robotic radiosurgery in patients with cervical carcinomaRadiation Oncology, 2013
- Comparison of intracavitary brachytherapy and stereotactic body radiotherapy dose distribution for cervical cancerBrachytherapy, 2012
- CyberKnife Boost for Patients with Cervical Cancer Unable to Undergo BrachytherapyFrontiers in Oncology, 2012
- International Brachytherapy Practice Patterns: A Survey of the Gynecologic Cancer Intergroup (GCIG)International Journal of Radiation Oncology - Biology - Physics (IJROBP), 2012
- State of the art on dose prescription, reporting and recording in Intensity-Modulated Radiation Therapy (ICRU report No. 83)Cancer/Radiothérapie, 2011
- Clinical outcome of protocol based image (MRI) guided adaptive brachytherapy combined with 3D conformal radiotherapy with or without chemotherapy in patients with locally advanced cervical cancerRadiotherapy and Oncology, 2011
- Stereotactic body radiation therapy: The report of AAPM Task Group 101Medical Physics, 2010
- An Analysis of the Accuracy of the CyberKnife: A Robotic Frameless Stereotactic Radiosurgical SystemNeurosurgery, 2003
- Reporting and analyzing dose distributions: A concept of equivalent uniform doseMedical Physics, 1997